通过确定脂蛋白 (a) 水平来重新分类低或中等心血管风险
Alberto Cordero1,2,3, José Ma Salinas4, María Amparo Quintanilla1
1Cardiology Department, Hospital Universitario de San Juan, 03550 Alicante, Spain.
Biomedicines
|November 27, 2025
概括
脂蛋白 (a) [Lp (a) ]测试在最初被评估为低风险或中等风险的个体中确定了显著的心血管风险. 这种测试还确定了对他类药物治疗的资格,改善了心血管疾病预防策略.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 临床生物化学 临床生物化学
背景情况:
- 脂蛋白 (Lp) 是已知的心血管疾病的独立风险因素.
- 对于全面的心血管风险评估,建议对Lp (a) 水平进行终身测定.
- 当前的风险分层模型可能无法完全捕捉与Lp (a) ]相关的风险.
研究的目的:
- 评估脂质蛋白 (Lp) 测试对心血管风险重新分类的影响.
- 根据低至中等风险队列中的Lp (a) 水平来评估对他类药物治疗的资格.
- 将Lp(a) 测量纳入现有的心血管风险预测工具,如SCORE2.
主要方法:
- 患有低或中等心血管风险的受试者 (SCORE2) 接受了Lp (a) 测定.
- 患有Lp (a) >50 mg/dL的个体被归类为风险较高的人.
- 根据已确定的治疗目标和Lp(a) 结果评估了类固醇药物的适用性.
主要成果:
- 22.1%的队列表现出Lp (a) 水平>50 mg/dL,表明心血管风险较高.
- 纳入Lp (a) 的风险从低风险转为中等风险的比例为22.6%,从中等风险转为高风险的比例为77.4%.
- 61.4%的受试者在Lp (a) 测试后有资格接受他类药物治疗.
结论:
- 脂蛋白 (a) [Lp (a) ]测试显著重新分类了大量最初被认为是低风险或中等风险的个人的心血管风险.
- 常规Lp(a) 测量确定了高比例的患者有资格接受他类药物治疗,增强了预防性心脏病治疗策略.
- 将Lp(a) 整合到SCORE2等风险得分中,可以提高心血管风险分层的准确性,并指导治疗决策.
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
537
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
537
Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301
Coronary Artery Disease IV: Preventive Measures
577
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
577
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Cholesterol: Significance and Regulation
1.2K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.2K
Atherosclerosis I: Introduction
835
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
835


